PCMA president calls for more off-patent drug competition
Following this week’s U.S. Senate Special Committee on Aging's hearing on "Sudden Price Spikes in Off-Patent Prescription Drugs," Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt called for this nation’s policymakers to make generic drugs more accessible. Read More »